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Background
Although aCL antibodies are often found in serum sam-
ples from patients with primary Sjögren's syndrome
(pSS), their clinical significance remains unclear. The aims
of this study were to investigate the prevalence of aCL
antibodies and their correlation with the main typical
clinical and serological manifestations in Chinese patients
with pSS.
Materials and methods
Patients were consecutively recruited among the patients
with pSS seen in our rheumatic department between
March 2001 and October 2007. All the included patients
met the revised European Community Criteria for pSS. All
patients fulfilling the clinical criteria for rheumatoid
arthritis (RA), SLE, polymyositis, systemic sclerosis or
other diffuse connective tissue diseases were excluded
from pSS group. Any patients with sarcoidosis, graft-ver-
sus-host disease, acquired immune deficiency syndrome
or preexisting lymphoma were also excluded.
Results
ACL antibodies were found in 26 (28%) patients; IgG-aCL
in 14 patients, IgM-aCL in 9 patients and IgA-aCL in 3
patients. Cutaneous vasculitis and concurrent autoim-
mune disease(thyroidal disease, primary biliary cirrhosis)
were more frequent in the aCL-positive group than in the
aCL-negative group(p < 0.05). Patients with positive aCL
presented a higher prevalence of positive ANA and hyper-
gammaglobulinemia(p < 0.05).
Conclusion
The prevalence of aCL antibodies in our patients with pSS
was 28% and are mainly IgG-aCL and IgM-aCL. ACL anti-
bodies may play a pathogenic role in patients with pSS.
Detection of aCL antibodies in patients with pSS may
indicate doctor to find if concurrent autoimmune diseases
(thyroidal disease, primary biliary cirrhosis) exist.
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